Alison M. Friedmann

2.3k total citations
56 papers, 1.3k citations indexed

About

Alison M. Friedmann is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine. According to data from OpenAlex, Alison M. Friedmann has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 17 papers in Public Health, Environmental and Occupational Health and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Alison M. Friedmann's work include Acute Lymphoblastic Leukemia research (16 papers), Sarcoma Diagnosis and Treatment (11 papers) and Childhood Cancer Survivors' Quality of Life (10 papers). Alison M. Friedmann is often cited by papers focused on Acute Lymphoblastic Leukemia research (16 papers), Sarcoma Diagnosis and Treatment (11 papers) and Childhood Cancer Survivors' Quality of Life (10 papers). Alison M. Friedmann collaborates with scholars based in United States, Canada and United Kingdom. Alison M. Friedmann's co-authors include Nancy J. Tarbell, Torunn I. Yock, Howard J. Weinstein, Shannon M. MacDonald, Cindy L. Schwartz, Steven N. Goodman, Harold P. Lehmann, Matthew Ladra, J. Adams and Barbara C. Fullerton and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Alison M. Friedmann

55 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison M. Friedmann United States 21 520 317 304 287 279 56 1.3k
Brian Greffe United States 17 343 0.7× 199 0.6× 202 0.7× 312 1.1× 275 1.0× 42 1.3k
Christine Mauz‐Körholz Germany 19 317 0.6× 656 2.1× 281 0.9× 207 0.7× 342 1.2× 87 1.5k
Maike de Wit Germany 26 1.0k 1.9× 692 2.2× 169 0.6× 195 0.7× 476 1.7× 88 2.5k
W Dörffel Germany 21 254 0.5× 872 2.8× 634 2.1× 455 1.6× 409 1.5× 48 1.5k
Purna Kurkure India 19 389 0.7× 101 0.3× 218 0.7× 191 0.7× 213 0.8× 91 1.2k
Woodrow Wells Canada 19 465 0.9× 1.3k 4.0× 141 0.5× 68 0.2× 548 2.0× 43 1.9k
Patrick Hilden United States 18 303 0.6× 168 0.5× 126 0.4× 85 0.3× 78 0.3× 76 1.1k
J. Bullimore United Kingdom 21 321 0.6× 335 1.1× 100 0.3× 84 0.3× 403 1.4× 42 1.2k
Barbara Sarina Italy 23 210 0.4× 530 1.7× 156 0.5× 51 0.2× 192 0.7× 76 1.7k
Arthur J. Provisor United States 22 602 1.2× 165 0.5× 213 0.7× 269 0.9× 147 0.5× 40 1.7k

Countries citing papers authored by Alison M. Friedmann

Since Specialization
Citations

This map shows the geographic impact of Alison M. Friedmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison M. Friedmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison M. Friedmann more than expected).

Fields of papers citing papers by Alison M. Friedmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison M. Friedmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison M. Friedmann. The network helps show where Alison M. Friedmann may publish in the future.

Co-authorship network of co-authors of Alison M. Friedmann

This figure shows the co-authorship network connecting the top 25 collaborators of Alison M. Friedmann. A scholar is included among the top collaborators of Alison M. Friedmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison M. Friedmann. Alison M. Friedmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Friedmann, Alison M., et al.. (2025). Adult onset wilms tumor. Radiology Case Reports. 20(3). 1755–1759.
2.
Mattano, Leonard A., Meenakshi Devidas, Kelly W. Maloney, et al.. (2021). Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331. Journal of Clinical Oncology. 39(14). 1540–1552. 22 indexed citations
3.
Llanos‐Chea, Alejandro, Jason M. Shapiro, Rachel W. Winter, et al.. (2021). Lymphoma in Pediatric-Onset Inflammatory Bowel Disease Treated with Infliximab Monotherapy: A Case Series. Digestive Diseases and Sciences. 67(1). 252–258. 1 indexed citations
4.
Friedmann, Alison M., et al.. (2019). Medical Options for the Adjuvant Treatment and Management of Pediatric Melanoma. Pediatric Drugs. 21(2). 71–79. 5 indexed citations
5.
Bartenstein, Diana W., Taylor M. Coe, Samantha C. Gordon, et al.. (2018). Lipofibromatosis-like neural tumor: Case report of a unique infantile presentation. JAAD Case Reports. 4(2). 185–188. 22 indexed citations
6.
Misra, Madhusmita, Pallavi Sagar, Alison M. Friedmann, Daniel P. Ryan, & Dennis C. Sgroi. (2016). Case 12-2016. New England Journal of Medicine. 374(16). 1565–1574. 4 indexed citations
7.
8.
Ladra, Matthew, Henry Mandeville, Andrzej Niemierko, et al.. (2015). Local Failure in Parameningeal Rhabdomyosarcoma Correlates With Poor Response to Induction Chemotherapy. International Journal of Radiation Oncology*Biology*Physics. 92(2). 358–367. 20 indexed citations
9.
Ladra, Matthew, Jackie Szymonifka, Anita Mahajan, et al.. (2014). Preliminary Results of a Phase II Trial of Proton Radiotherapy for Pediatric Rhabdomyosarcoma. Journal of Clinical Oncology. 32(33). 3762–3770. 91 indexed citations
10.
11.
Ladra, Matthew, Anita Mahajan, David R. Grosshans, et al.. (2014). A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study. Radiotherapy and Oncology. 113(1). 77–83. 73 indexed citations
12.
Metzger, Monika L., Howard J. Weinstein, Melissa M. Hudson, et al.. (2012). Association Between Radiotherapy vs No Radiotherapy Based on Early Response to VAMP Chemotherapy and Survival Among Children With Favorable-Risk Hodgkin Lymphoma. JAMA. 307(24). 2609–16. 73 indexed citations
13.
Saleeby, Chadi M. El, Brian E. Grottkau, Alison M. Friedmann, Sjirk J. Westra, & Aliyah R. Sohani. (2011). Case 4-2011. New England Journal of Medicine. 364(6). 552–562. 7 indexed citations
14.
Aftandilian, Catherine & Alison M. Friedmann. (2010). Burkitt Lymphoma With Pancreatic Involvement. Journal of Pediatric Hematology/Oncology. 32(8). e338–e340. 4 indexed citations
15.
Friedmann, Alison M.. (2008). Evaluation and Management of Lymphadenopathy in Children. Pediatrics in Review. 29(2). 53–60. 40 indexed citations
16.
Yock, Torunn I., Robert J. Schneider, Alison M. Friedmann, et al.. (2005). Proton radiotherapy for orbital rhabdomyosarcoma: Clinical outcome and a dosimetric comparison with photons. International Journal of Radiation Oncology*Biology*Physics. 63(4). 1161–1168. 107 indexed citations
17.
Friedmann, Alison M., Esther Oliva, Anthony L. Zietman, & Suzanne L. Aquino. (2003). Case 9-2003. New England Journal of Medicine. 348(12). 1150–1158. 1 indexed citations
18.
Friedmann, Alison M., et al.. (2002). Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylatic, platelet transfusions. Transfusion Medicine Reviews. 16(1). 34–45. 118 indexed citations
19.
20.
Friedmann, Alison M., et al.. (1998). Fatal Autoimmune Hemolytic Anemia in a Child Due to Warm-Reactive Immunoglobulin M Antibody. Journal of Pediatric Hematology/Oncology. 20(5). 502–505. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Greffe Breakdown of academic impact, for papers by Christine Mauz‐Körholz Breakdown of academic impact, for papers by Maike de Wit Breakdown of academic impact, for papers by W Dörffel Breakdown of academic impact, for papers by Purna Kurkure Breakdown of academic impact, for papers by Woodrow Wells Breakdown of academic impact, for papers by Patrick Hilden Breakdown of academic impact, for papers by J. Bullimore Breakdown of academic impact, for papers by Barbara Sarina Breakdown of academic impact, for papers by Arthur J. Provisor
Rankless by CCL
2026